Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$23.2K Buy
193
+18
+10% +$2.08K 0.01% 346
2025
Q4
$18.4K Hold
175
0.01% 361
2025
Q3
$14.7K Hold
175
﹤0.01% 411
2025
Q2
$13.8K Buy
175
+1
+0.6% +$79 ﹤0.01% 412
2025
Q1
$15.7K Hold
174
0.01% 375
2024
Q4
$17.3K Sell
174
-43
-20% -$4.43K 0.01% 364
2024
Q3
$24.7K Hold
217
0.01% 308
2024
Q2
$26.9K Sell
217
-83
-28% -$10.7K 0.01% 288
2024
Q1
$39.6K Buy
300
+18
+6% +$2.22K 0.02% 263
2023
Q4
$30.7K Buy
+282
New +$29.3K 0.02% 280

Other funds holding MRK

Tidemark's MRK Position: Q1 2026 in Review

Tidemark increased its Merck (MRK) stake by 10% in Q1 2026, buying an estimated $2.08K and bringing the position to 193 shares worth $23.2K. The position accounts for 0.01% of the portfolio, ranked #346.

Tidemark first reported a position in MRK in Q4 2023 and has held it in 10 quarters since. The position peaked at $39.6K in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Tidemark held 193 shares of Merck worth $23.2K as of Q1 2026.
  • Tidemark bought 18 Merck shares in Q1 2026, an estimated $2.08K.
  • Merck made up 0.01% of Tidemark's portfolio in Q1 2026, its #346 holding.
  • Tidemark first reported a position in Merck in Q4 2023 and has held it in 10 quarters since.
  • Tidemark's Merck position peaked at $39.6K in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Tidemark's 13F filing for Q1 2026, filed 7 May 2026.